Bentham Science Logo

Track Your Manuscript:


Current Signal Transduction Therapy

Volume 16, 3 Issues, 2021
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access

Contents

Current Signal Transduction Therapy, Volume 8 - Number 2



Brefeldin A Inhibits Cancer Stem Cell Properties in Human Lung Cancer Cells

, 8(2): 113 - 118

Chao-Neng Tseng, Chung-Lung Cho, Tzan-Wen Chen, Chien-Chih Chiu, Hsueh-Wei Chang, Fang-Rong Chang and Yung-Fu Chang


DOI: 10.2174/15743624113086660005






Homology-Based Design for Selective GSK-3 Peptide Inhibitors: Patent Applications and Type 2 Diabetes Mellitus

, 8(2): 156 - 164

Camila Chaves Santos, Rodrigo Chaves, Ana Cristina Borges, Michelle Oliveira de Castro and Helio Miranda Costa-Junior


DOI: 10.2174/15743624113086660007





Editor-in-Chief

Jingxuan Yang
Department of Medicine
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog